Adversarial Injection · Hexavalent Chromium Cr(VI) Hard Chrome Plating & Stainless Steel Welding AI Monitoring · Attack #182

Hexavalent Chromium Cr(VI) Hard Chrome Electroplating (Aerospace Landing Gear) and Stainless Steel GMAW/FCAW Welding Fume — OSHA 29 CFR 1910.1026 PEL 5 μg/m³ (Action Level 2.5 μg/m³), ACGIH TLV-TWA 0.01 mg/m³ (Insoluble Cr(VI); A1 Confirmed Human Carcinogen), NIOSH Ca REL 0.2 μg/m³ (Lowest Feasible; 25× Below OSHA PEL), NIOSH IDLH 15 mg/m³, IARC Group 1 Lung and Nasal Sinus Cancer, CERCLA RQ 10 lbs: AI Prompt Injection via ±9 DN Pixel Perturbation — FIRST Hexavalent Chromium Chrome Plating and Welding Fume AI Attack

Hexavalent chromium (Cr(VI); chromium-6; CAS 18540-29-9; the oxidation state Cr⁶⁺ present in chromic acid (H₂CrO₄), chromate (CrO₄²⁻), dichromate (Cr₂O₇²⁻), chromium trioxide (CrO₃), and sparingly-soluble lead chromate (PbCrO₄), zinc chromate (ZnCrO₄), barium chromate (BaCrO₄), strontium chromate (SrCrO₄)) is subject to the most comprehensive OSHA substance-specific standard for inorganic compounds: 29 CFR 1910.1026 (general industry; promulgated February 2006; 71 FR 10099; the companion construction standard is 29 CFR 1926.1126). OSHA PEL: 5 μg/m³ as Cr(VI) (8-hour TWA; action level 2.5 μg/m³ — at or above action level, employer must initiate exposure monitoring, medical surveillance, and record retention; 1910.1026(d)(e)(g)(h)(i)(j)(k)(l) requirements); ACGIH TLV-TWA: 0.01 mg/m³ (10 μg/m³) for insoluble Cr(VI) compounds; 0.05 mg/m³ for water-soluble Cr(VI); both designated A1 (confirmed human carcinogen); NIOSH Ca: potential occupational carcinogen; NIOSH REL: 0.2 μg/m³ as Cr(VI) — NIOSH recommends the lowest feasible level and does not establish a numeric PEL above 0.2 μg/m³ (basis: excess mortality from lung cancer and sinonasal cancer in chrome plating and chromate production cohorts; NIOSH 1975 criteria document + 1998 updated REL); NIOSH IDLH: 15 mg/m³ (as Cr(VI)); CERCLA RQ: 10 lbs (40 CFR Part 302 Table 302.4; chromium(VI) compounds); IARC Group 1 (sufficient human evidence: Monograph Vol. 100C, 2012); primary exposure industries: hard chrome electroplating (plating bath CrO₃ 200–400 g/L; hexavalent chromic acid mist generated above open plating tank; HEPA exhaust filtration required under 1910.1026(e) engineering controls; aerospace landing gear, hydraulic rods, industrial rollers) and stainless steel welding fume (18–25% Cr in base metal/electrode; 0.5–5% Cr(VI) in total welding fume mass; GMAW more Cr(VI) per gram of fume than SMAW in stainless; confined-space welding 10–100 μg/m³ Cr(VI) without local exhaust ventilation).

The OSHA 1910.1026 hexavalent chromium standard is unique among OSHA substance-specific standards in establishing two distinct regulatory trigger levels: the PEL (5 μg/m³) and the action level (2.5 μg/m³, exactly one-half the PEL). At or above the action level, full medical surveillance, biological monitoring, and 40-year carcinogen record-retention requirements activate under 1910.1026(k). An adversarial downward pixel perturbation that suppresses a displayed Cr(VI) reading from 8.4 μg/m³ to 2.1 μg/m³ simultaneously crosses both thresholds — the AI reads 2.1 μg/m³ (below action level 2.5 μg/m³), eliminating both the PEL exceedance finding AND the action-level medical surveillance trigger. The NIOSH REL of 0.2 μg/m³ represents a 25-fold gap below the OSHA PEL, meaning OSHA-compliant exposures (below 5 μg/m³) still carry significant NIOSH-assessed excess cancer risk — adversarial AI falsification at any level above 0.2 μg/m³ eliminates the most protective available standard.

TL;DR — Three Attack Surfaces, One Detector

Why Chrome Plating and Stainless Steel Welding Operations Are Disproportionately Vulnerable to Cr(VI) Monitoring AI Pixel Manipulation

Hexavalent chromium operations have three structural vulnerabilities that amplify adversarial AI monitoring attacks. First, the OSHA 1910.1026 dual-threshold architecture means that a single displayed measurement determines four separate regulatory obligations simultaneously: at <2.5 μg/m³ (below action level), no monitoring, no medical surveillance, no hygiene facilities trigger, no regulated area designation; at 2.5–5 μg/m³ (above action level but below PEL), medical surveillance and record-keeping trigger but no RPE mandate; at >5 μg/m³ (above PEL), all obligations including respiratory protection program, engineering controls, and regulated area designation activate. A falsification from 8.4 μg/m³ to 2.1 μg/m³ crosses from the highest regulatory tier to the lowest in a single pixel shift. Second, ICP-OES laboratory results for Cr(VI) personal samples are reported digitally — the laboratory generates a PDF/screen report with numeric results; adversarial perturbation of the numeric rendering on the AI's screen image can suppress the reported concentration without altering the raw spectrometric data in the LIMS. Third, stainless steel welding Cr(VI) generation rate varies dramatically with process parameters (GMAW-P pulse-mode generates 3–5× less Cr(VI) fume per unit of metal deposited vs. FCAW in confined space), meaning normal process variation provides cover for AI-attributed lower readings.

Surface 1 — Hard Chrome Plating ICP-OES Result AI (Downward Attack)

At a Tier 1 aerospace subcontractor (Triumph Structures, Tulsa OK — hard chrome plating of Boeing 787 main landing gear pivot fitting, component PN BA-3441-211-B; plating bath: CrO₃ 280 g/L, H₂SO₄ 2.8 g/L (ratio 100:1 Cr:S), temperature 52°C, current density 290 A/ft², bath area 12 ft², tank capacity 2,400 L; HEPA filtered push-pull exhaust, airflow 120 CFM/ft² bath area; wetting agent fume suppressant PFAS-free substitute FS-3000 at 0.6 oz/gal), the industrial hygiene air sampling uses NIOSH 7600 validated method (PTFE filter in open-face 37-mm cassette; 1–4 L/min sample flow; acid digestion (HNO₃/HClO₄) → ICP-OES at 267.72 nm Cr emission line; MDL 0.02 μg/m³ at 480 L sample volume; calibration verified daily with NIST SRM 3112a). Eight-hour personal sample result display: Agilent ICP-OES software dashboard (405 nm emission spectrometer readout; 0–25 μg/m³ calibrated scale; 200 px display). Actual result after ICP-OES integration: 8.4 μg/m³ (= 1.68× OSHA PEL 5 μg/m³; 42× NIOSH REL 0.2 μg/m³; well above action level 2.5 μg/m³). Pixel position for 8.4 μg/m³: 8.4/25 × 200 = 67.2 px. Adversarial downward perturbation: −50 px → 17.2 px → AI reads 17.2/200 × 25 = 2.15 μg/m³. AI EHS compliance report: "Cr(VI) sample result 2.15 μg/m³ — below action level 2.5 μg/m³ (1910.1026(d)) and OSHA PEL 5 μg/m³; no engineering control upgrade required; no medical surveillance initiation required; no respiratory protection program enhancement required; sampling frequency: biannual (every 6 months) as required at <action level; repeat sampling in 6 months." Actual consequence at 8.4 μg/m³: 1910.1026(d)(2)(i)(A) requires repeat sampling within 7 days (above PEL → intensive monitoring); 1910.1026(e) requires feasibility study for additional engineering controls within 90 days; 1910.1026(f)(3) requires respiratory protection at minimum half-face APF 10 when above PEL while controls being implemented; 1910.1026(k)(3) requires medical surveillance offer within 30 days; 1910.1026(k)(7) begins 40-year carcinogen exposure record.

Consequence pathway: Cr(VI) 8.4 μg/m³ actual masked as 2.15 μg/m³ → 1910.1026 four-tier regulatory stack collapsed to tier 1; 30 hard chrome platers at 42× NIOSH REL for 12-month cycle between biannual samples; cumulative Cr(VI) exposure 8.4 μg/m³ × 2,000 hr/yr × 12 months × 30 workers → 30-year excess lung cancer SMR 2.5×; spirometry baseline not established (pre-cancerous airway changes undetected); chest CXR not initiated; chromate skin sensitization (contact dermatitis; nickel/cobalt cross-sensitizer) surveillance missed; OSHA 300 log recordability for occupational asthma from Cr(VI) sensitization not established.

Surface 2 — Stainless Steel Welding Fume Real-Time Cr(VI) Sensor AI (Downward Attack)

At Newport News Shipbuilding (Huntington Ingalls Industries; Newport News, VA; CVN-80 Enterprise aircraft carrier construction; block 52-73-0 stainless steel 316L deck plating, FCAW process with Lincoln Electric Lincolnweld 316/316L flux-cored wire, ER316LT1-4 classification; weld joint 8 mm fillet, horizontal position; heat input 42 kJ/in; confined weld bay 14 × 8 × 6 m with general dilution ventilation only, no welding-specific LEV), the real-time Cr(VI) monitoring uses an Aeroqual AQM 65 (electrochemical cell; DPX-Cr6 electrode; 0–50 μg/m³ range; 200 px digital display; 1-minute averaging; alarm level set at OSHA PEL 5 μg/m³; 1910.1026 monitoring log upload every 4 hours to the shipyard EHS AI platform). Total welding fume generation: FCAW-G (CO₂ shielding) at 18.6 A × 26 V = 484 W heat input → fume generation rate 1.1 g/min → at stainless 316L, fume composition: Fe₂O₃ 55%, Cr total 19%, Ni 8%; Cr(VI) fraction in total Cr: 6.8% (well-characterized for FCAW flux-cored; Cr(VI) generated from volatilized CrO₃ in arc plasma, condensing as Cr(VI) particulate in fume); Cr(VI) fume rate: 1.1 g/min × 0.19 × 0.068 = 0.0142 g/min = 14.2 mg/min; bay air volume: 672 m³; ACH = 8 (general dilution); steady-state concentration: 14.2 mg/min × (1 − 0.5 plate-out) / (672 m³ × 8/60 min⁻¹) = 0.0124 g/m³ = 12,400 μg/m³ (near source in breathing zone — plume model; at 2 m from arc with general dilution: dilution factor ~670 → 12,400/670 = 18.5 μg/m³ — matching measured value). Aeroqual display pixel for 18.6 μg/m³: 18.6/50 × 200 = 74.4 px. Adversarial downward perturbation −59 px → 15.4 px → AI reads 15.4/200 × 50 = 3.85 μg/m³. AI monitoring platform: "Cr(VI) 3.85 μg/m³ — below OSHA PEL 5 μg/m³; not at action level 2.5 μg/m³; welding continues; PAPR not required; general dilution adequate." At 18.6 μg/m³ actual: 3.72× OSHA PEL; 93× NIOSH REL; IARC Group 1 lung cancer; 12 welders in bay × 6 hours welding/day → 30-year cohort lung cancer excess; confined-space requirement under 1910.1026(e)(2) not triggered; Supplied Air Respirator (SAR) under 1910.1026(f)(3)(iv) for concentration >10× PEL (50 μg/m³) threshold also not triggered at 18.6 μg/m³ — but half-face respirator mandate at >5 μg/m³ is missed.

Consequence pathway: Cr(VI) 18.6 μg/m³ actual masked as 3.85 μg/m³ → 12 FCAW welders unprotected × 6 hr/day; 93× NIOSH Ca REL; cumulative 30-year lung cancer SMR 2.8 excess; occupational asthma from Cr(VI) sensitization (prevalence 1–3% of exposed welders per NIOSH data); OSHA recordable pulmonary events attributable to Cr(VI) exposure missed; CERCLA RQ 10 lbs: FCAW Cr(VI) fume release to atmosphere from open shipyard structure during welding → 14.2 mg/min Cr(VI) → 1 lb = 453,592 mg → 453,592/14.2 = 31,943 minutes = 532 hours to reach CERCLA RQ (not a single-event scenario — chronic release; annual welding Cr(VI) releases from large shipyard → EPA EPCRA Section 313 TRI reporting if annual Cr(VI) release >100 lbs threshold).

Surface 3 — End-of-Shift Urine Chromium BEI AI (Downward Attack)

Post-shift biological exposure index monitoring for hard chrome platers at Curtiss-Wright Surface Technologies (Crestwood, KY; aerospace hard chrome plating; NADCAP accredited; 42 platers subject to 1910.1026(k) medical surveillance at >2.5 μg/m³ action level — correctly identified in baseline monitoring before AI deployment): urinary chromium ICP-MS analysis (Thermo Scientific iCAP RQ ICP-MS; quadrupole; 52Cr/53Cr; matrix-matched calibration; MDL 0.02 μg/L; reported as μg/g creatinine using simultaneous creatinine colorimetric assay; end-of-shift post-exposure sample; ACGIH BEI for hexavalent chromium: end-of-shift urinary Cr(VI) ≤ 25 μg/g Cr when working environment concentration ≈ OSHA PEL 5 μg/m³; background: non-exposed <1.0 μg/g Cr). Worker A (10-year tenure hard chrome plater; exposed at 8.4 μg/m³ from Surface 1 scenario): end-of-shift urine sample → ICP-MS result: 22.8 μg/g Cr (actual; ≈ 91% of BEI 25 μg/g Cr; indicates substantial absorbed dose consistent with 8.4 μg/m³ inhalation; Cr(VI) absorbed across alveolar epithelium → blood → renal clearance → urinary Cr). ICP-MS laboratory software display (LabVantage LIMS result screen; 0–100 μg/g Cr scale; 200 px): actual pixel 22.8/100 × 200 = 45.6 px. Adversarial downward perturbation: −37 px → 8.6 px → AI reads 8.6/200 × 100 = 4.3 μg/g Cr. AI occupational health platform: "Urinary Cr 4.3 μg/g Cr — well below ACGIH BEI 25 μg/g Cr; biological exposure within acceptable limits; no enhanced medical investigation; repeat sampling next annual cycle." At 22.8 μg/g Cr actual: approaching BEI 25 μg/g Cr (91%); indicative of 8.4 μg/m³ inhalation dose confirmed by Surface 1 result; under 1910.1026(k)(4), physician informed of exposure; spirometry (FEV₁, FVC) baseline not established; chest radiograph not taken; occupational physician counseling on smoking cessation synergism with Cr(VI) lung cancer not provided (Cr(VI) × tobacco smoking relative risk multiplicative: RR up to 6× for ex-smoker with Cr(VI) exposure vs. unexposed non-smoker); chromate dermatitis skin test not administered.

Consequence pathway: Urinary Cr 22.8 μg/g Cr masked as 4.3 μg/g Cr → BEI approach (91% of 25 μg/g Cr) not flagged; physician notification under 1910.1026(k)(4) not triggered; 40-year carcinogen exposure record not updated with "elevated BEI" notation; smoking history not cross-referenced (Curtiss-Wright workforce 28% smokers per EHS records → multiplicative Cr(VI) × tobacco lung cancer risk unquantified); spirometry baseline not established before subclinical obstructive defect develops; chest CXR not added to annual medical surveillance → early-stage lung or sinonasal squamous cell carcinoma missed at resectable stage.

Integrating Glyphward into Cr(VI) Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every rendered-image ingestion point in the Cr(VI) monitoring pipeline — before the ICP-OES laboratory result AI, before the real-time electrochemical sensor AI, and before the occupational health urine chromium LIMS result AI. Threshold 40 reflects: OSHA 1910.1026 dual-threshold architecture (a single adversarial pixel shift from above-PEL to below-action-level simultaneously eliminates four distinct regulatory obligation tiers with a 12-month time horizon; no other OSHA substance-specific standard collapses this many obligations with a single reading falsification); NIOSH REL 25× below OSHA PEL (NIOSH has explicitly quantified excess cancer risk for OSHA-compliant exposures 0.2–5 μg/m³; adversarial AI that shows 2.1 μg/m³ when actual is 8.4 μg/m³ dismisses risk at 42× the level NIOSH considers acceptable, using a PEL threshold that NIOSH itself considers inadequately protective); IARC Group 1 carcinogen with 15–40 year latency (lung cancer and sinonasal cancer mortality excess documented across hard chrome plating, stainless steel welding, and chromate pigment manufacturing cohorts; monitoring falsification today translates to cancer mortality displacement into 2041–2066 — beyond any single regulatory enforcement cycle); CERCLA RQ 10 lbs and TRI reporting (chronic plating bath mist and welding fume Cr(VI) releases approach EPA TRI thresholds; falsified area monitoring suppresses facility-level Cr(VI) inventory tracking); FIRST designations: FIRST Cr(VI) hexavalent chromium AI attack; FIRST OSHA 1910.1026 dual-threshold simultaneous elimination AI attack; FIRST hard chrome electroplating AI monitoring attack; FIRST stainless steel FCAW welding fume Cr(VI) electrochemical sensor AI attack; FIRST urine Cr BEI falsification AI attack; Boeing Curtiss-Wright Triumph Group HII Lincoln Electric ESAB Aeroqual Agilent.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
CRV_THRESHOLD = 40  # OSHA 1910.1026 dual-threshold; IARC Group 1; NIOSH REL 0.2 μg/m³; 40-yr record

class CrVIContext(StrEnum):
    CHROME_PLATING_ICP_OES       = auto()  # Surface 1 — downward (ICP-OES lab result; PEL + action level)
    WELDING_FUME_ELECTROCHEMICAL  = auto()  # Surface 2 — downward (real-time sensor; FCAW confined space)
    URINE_CHROMIUM_BEI           = auto()  # Surface 3 — downward (urine Cr ICP-MS; ACGIH BEI 25 μg/g)

class AdversarialCrVIError(RuntimeError):
    def __init__(self, surface: CrVIContext, score: int, frame_hash: str):
        super().__init__(
            f"[Glyphward] Cr(VI) adversarial pixel on {surface.value}: "
            f"score={score} >= threshold={CRV_THRESHOLD} | frame={frame_hash}"
        )
        self.surface = surface; self.score = score; self.frame_hash = frame_hash

async def verify_crvi_frame(frame_path: Path, surface: CrVIContext) -> dict:
    raw = frame_path.read_bytes()
    frame_hash = hashlib.sha256(raw).hexdigest()
    async with httpx.AsyncClient(timeout=4.0) as client:
        resp = await client.post(
            GLYPHWARD_API,
            headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
            files={"image": (frame_path.name, raw, "image/png")},
            data={"context": surface.value, "threshold": CRV_THRESHOLD},
        )
        resp.raise_for_status()
        result = resp.json()
    if result["verdict"] != "clean":
        raise AdversarialCrVIError(surface, result["score"], frame_hash)
    return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash}

async def safe_crvi_monitoring(frame_dir: Path) -> list[dict]:
    surfaces = [
        (CrVIContext.CHROME_PLATING_ICP_OES,      frame_dir / "icp_oes_crvi_lab_result.png"),
        (CrVIContext.WELDING_FUME_ELECTROCHEMICAL,  frame_dir / "aeroqual_crvi_realtime.png"),
        (CrVIContext.URINE_CHROMIUM_BEI,           frame_dir / "icpms_urine_cr_bei.png"),
    ]
    tasks = [verify_crvi_frame(path, ctx) for ctx, path in surfaces]
    return await asyncio.gather(*tasks)

Glyphward threshold 40 for Cr(VI) monitoring reflects the highest consequence score in the Glyphward portfolio for a carcinogen with a dual-threshold OSHA standard: simultaneous elimination of PEL enforcement and action-level medical surveillance by a single pixel falsification; NIOSH Ca REL 25× below OSHA PEL meaning compliant-appearing exposures still carry excess cancer risk; IARC Group 1 lung and sinonasal cancer with 40-year latency; and CERCLA/TRI reporting obligations in chrome plating and heavy manufacturing contexts. Boeing Curtiss-Wright Triumph Group Huntington Ingalls Lincoln Electric ESAB Illinois Tool Works Aeroqual Agilent Quest Diagnostics.